好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Initial EEG Predicts Outcomes in a Trial of Levetiracetam vs. Fosphenytoin for Seizure Prevention in Patients with Severe Traumatic Brain Injury
Critical Care/Emergency Neurology/Trauma
(-)
004
Authors/Disclosures
Linda A. Staley, MD (Memorial) No disclosure on file
Kathryn S. Nevel, MD (Indiana University School of Medicine) Dr. Nevel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Nevel has received publishing royalties from a publication relating to health care. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Interviewer with Continuum Audio.
Lori A. Shutter, MD, FCCM, FNCS, FAAN, FAAN (UPMC Dept of Critical Care Medicine) The institution of Dr. Shutter has received research support from NIH. Dr. Shutter has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FAAN (University of Alabama At Birmingham) Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.